Conexeu Sciences to Ring Nasdaq Bell June 10 After CXU Platform Achieves B.R.E.A.S.T Milestone
CNXU•Conexeu Sciences will ring the Nasdaq Closing Bell on June 10 at MarketSite in New York in celebration of its recent Nasdaq listing and trading commencement under the new ticker. The ceremony follows its development of the B.R.E.A.S.T 3D-bioprinted breast matrix and launch of a Wake Forest preclinical program.
1. Nasdaq Closing Bell Ceremony Details
Conexeu Sciences will ring the Nasdaq Closing Bell on Wednesday, June 10, 2026, at the Nasdaq MarketSite in New York City to mark its recent public listing and the commencement of trading under the ticker. President and CEO Miles Harrison will participate alongside board members, co-founders, senior leadership, employees and key stakeholders.
2. CXU Platform and B.R.E.A.S.T Development
The ceremony follows Conexeu’s announcement of its BIO-REGENERATIVE ERGONOMICALLY ARCHITECTED SMART TISSUE™ (B.R.E.A.S.T), a 3D-bioprinted regenerative breast matrix built on the proprietary CXU™ extracellular matrix platform. The company also launched a preclinical development program at the Wake Forest Institute for Regenerative Medicine to advance its regenerative tissue therapies.
3. Technology Features and Regulatory Path
Conexeu’s lead candidate, Ten Minute Tissue™, remains fluid at room temperature and transitions to a stable gel at body temperature within ten minutes, demonstrating enhanced healing dynamics and low inflammatory profile in preclinical studies. The company targets multi-billion-dollar markets in wound care, periodontal and aesthetic applications and plans a predicate-based 510(k) submission in early 2027.
